| Literature DB >> 26661524 |
Cameron Best1, Ekene Onwuka2, Victoria Pepper3, Malik Sams1, Jake Breuer1, Christopher Breuer4.
Abstract
Advancements in biomaterial science and available cell sources have spurred the translation of tissue-engineering technology to the bedside, addressing the pressing clinical demands for replacement cardiovascular tissues. Here, the in vivo status of tissue-engineered blood vessels, heart valves, and myocardium is briefly reviewed, illustrating progress toward a tissue-engineered heart for clinical use. ©2016 Int. Union Physiol. Sci./Am. Physiol. Soc.Mesh:
Substances:
Year: 2016 PMID: 26661524 PMCID: PMC4698452 DOI: 10.1152/physiol.00018.2015
Source DB: PubMed Journal: Physiology (Bethesda) ISSN: 1548-9221